SCHEDULE 13G

CytomX Therapeutics Inc

Common Stock, par value $0.00001 per share · CUSIP: 23284F105

Event date: 2025-05-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Point72 Asset Management, L.P.

  Shares: 13,094,400.00 · Class: 8.3%

• Point72 Capital Advisors, Inc.

  Shares: 13,094,400.00 · Class: 8.3%

• Steven A. Cohen

  Shares: 13,094,400.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.